Turkish Journal of Biology
Volume 39

Number 3

Article 16

1-1-2015

Investigation of the in vivo interaction between ß-lactamase and
its inhibitor protein
NİLAY BÜDEYRİ GÖKGÖZ
SİMAY YALAZ
NAZE GÜL AVCI
GİZEM BULDUM
ELİF ÖZKIRIMLI ÖLMEZ

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
GÖKGÖZ, NİLAY BÜDEYRİ; YALAZ, SİMAY; AVCI, NAZE GÜL; BULDUM, GİZEM; ÖLMEZ, ELİF ÖZKIRIMLI;
and AKBULUT, BERNA SARIYAR (2015) "Investigation of the in vivo interaction between ß-lactamase and
its inhibitor protein," Turkish Journal of Biology: Vol. 39: No. 3, Article 16. https://doi.org/10.3906/
biy-1409-83
Available at: https://journals.tubitak.gov.tr/biology/vol39/iss3/16

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Investigation of the in vivo interaction between ß-lactamase and its inhibitor
protein
Authors
NİLAY BÜDEYRİ GÖKGÖZ, SİMAY YALAZ, NAZE GÜL AVCI, GİZEM BULDUM, ELİF ÖZKIRIMLI ÖLMEZ, and
BERNA SARIYAR AKBULUT

This article is available in Turkish Journal of Biology: https://journals.tubitak.gov.tr/biology/vol39/iss3/16

Turkish Journal of Biology

Turk J Biol
(2015) 39: 485-492
© TÜBİTAK
doi:10.3906/biy-1409-83

http://journals.tubitak.gov.tr/biology/

Research Article

Investigation of the in vivo interaction between β-lactamase
and its inhibitor protein
1

2

1

1

Nilay BÜDEYRİ GÖKGÖZ , Simay YALAZ , Naze Gül AVCI , Gizem BULDUM ,
2
1,
Elif ÖZKIRIMLI ÖLMEZ , Berna SARIYAR AKBULUT *
1
Bioengineering Department, Marmara University, Göztepe Campus, Kadıköy, İstanbul, Turkey
2
Chemical Engineering Department, Boğaziçi University, Bebek, İstanbul, Turkey
Received: 30.09.2014

Accepted/Published Online: 04.02.2015

Printed: 15.06.2015

Abstract: The affinity of β-lactamase inhibitory protein (BLIP) for TEM-1 β-lactamase has raised hopes in the challenge of proteinbased inhibitor discovery for β-lactamase-mediated antibiotic resistance. Currently, the effect of the formation of the β-lactamase:BLIP
complex in vivo in β-lactam resistant bacteria is an open question. The scarcity of information to the extent to which BLIP can impair
β-lactamase activity inside cells has urged us to assess the in vivo efficacy of BLIP as a potent β-lactamase inhibitor. To this end,
β-lactamase and BLIP were coexpressed in Escherichia coli. Simultaneous expression of β-lactamase and BLIP and the formation of
the TEM-1 β-lactamase:BLIP complex in the periplasmic space of E. coli were verified by electrophoretic and Western blot techniques.
Growth profiles of the cells expressing both β-lactamase and its protein inhibitor, complemented with β-lactamase activity measurements,
suggested that BLIP synthesis retarded cell growth and reduced β-lactamase activity. Although co-expression of β-lactamase and its
protein inhibitor did not completely impair cell growth, the specificity of BLIP enabled it to bind β-lactamase in the bacterial periplasm,
regardless of the crowding components.
Key words: β-lactamase, antibiotic resistance, BLIP

1. Introduction
β-lactam antibiotics hold great importance in healing
diverse bacterial infections. The function of these wonder
drugs is to block the synthesis of the bacterial cell wall
by binding the periplasmic bacterial transpeptidases
(also known as penicillin-binding proteins, PBPs) that
are responsible for the formation of oligopeptide crosslinks in the peptidoglycan layer of the bacterial cell wall.
The interruption of the peptidoglycan formation results
in loss of cell wall integrity and ultimately the cells die.
Unfortunately, the irresponsible use of these antibiotics
has led to a rise in the number of antibiotic resistant
bacteria (Essack, 2001; Majiduddin et al., 2002; Adelowo
and Fagade, 2012; Chanda et al., 2013). One mechanism by
which these bacteria acquire resistance is by β-lactamases.
The production of this enzyme renders the antibiotic
ineffective by hydrolyzing the amide bond of the β-lactam
ring before the antibiotic can bind PBPs (Frère, 1995;
Matagne et al., 1998). The rapid transfer of the β-lactamase
gene between organisms via plasmids is a major clinical
problem since it contributes to an increase in the number
of resistant bacteria (Blazquez et al., 1993).
* Correspondence: berna.akbulut@marmara.edu.tr

TEM-1 β-lactamase is one of the most prevalent
plasmid-encoded β-lactamases and its presence constitutes
the main reason for antibiotic resistance in gram-negative
bacteria. This periplasmic enzyme retains hydrolytic
activity against a broad range of antibiotics (Huang et al.,
1996). One strategy to counteract β-lactamase-mediated
antibiotic resistance is combination therapies of β-lactam
antibiotics with β-lactamase inhibitors such as clavulanic
acid (Martinez et al., 1987). These combination therapies
have proven to be effective in combating antibiotic
resistance; however, bacteria continue to evolve their
defense mechanisms against available therapies by
producing inhibitor resistant β-lactamases (Blazquez et al.,
1993). In this context, protein-based inhibitors hold great
promise since they interact with the target proteins with
high affinity.
One protein inhibitor of β-lactamases that has been
extensively studied is the β-lactamase inhibitory protein
(BLIP), isolated from Streptomyces clavuligerus (Doran et
al., 1990). BLIP is a 17.5 kDa protein that binds TEM-1
β-lactamase and hinders its hydrolytic activity (Strynadka
et al., 1994). The well-established affinity between TEM-1
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β-lactamase and BLIP has been the focus of a number of
recent studies to design new tools. Using this interaction,
Yuan et al. (2009) proposed a genetic screen for BLIP
function, Hanes et al. (2010) developed a simple and robust
pulse proteolysis method focusing on binding affinity, and
Fryszczyn et al. (2011) offered an improvement in phage
display technology. FRET-based techniques that utilize
the TEM-1 β-lactamase:BLIP interaction were used to
measure binding in the cytoplasm of HeLa cells to test
protein association in a crowded environment, and for
high-throughput analysis of protein-protein interactions
(Khait and Schreiber, 2012; Phillip et al., 2012a, 2012b).
The TEM-1:BLIP interface served as a model in the
development of methods for predicting protein–protein
interactions and for protein docking (Strynadka et al.,
1994; Robert and Janin, 1998).
Furthermore, the interaction of BLIP with TEM-1
guided BLIP based peptide design efforts (Huang et al.,
2003; Phichith et al., 2010; Alaybeyoglu et al., 2015). Even
though these peptides promise great potential as drugs
and easier cell penetration than a protein, their inhibition
constant values remain at around 100 micromolars, which
is too low for clinical studies. The delivery of proteins inside
the cell remains a huge obstacle in the design of protein
drugs. However, the inhibition constant of BLIP is 0.3
nM (Rudgers et al., 2001), which makes it is an attractive
protein for future drug design and delivery efforts.
In an effort to describe and characterize the in
vivo behavior of the TEM-1:BLIP interaction, the two
proteins were expressed simultaneously in E. coli and
the extent to which this interaction affected cell viability
was investigated. The key objectives of this study were
to: 1) demonstrate the binding between β-lactamase and

BLIP in the periplasmic extract; 2) achieve simultaneous
β-lactamase and BLIP synthesis; and 3) evaluate the effect
of the in vivo interaction between β-lactamase and BLIP on
cell viability. The findings obtained in this study contribute
to a better understanding of the in vivo inhibition of
β-lactamase by BLIP and open up a new perspective for
investigating the potential BLIP derived inhibitors binding
to β-lactamase.
2. Materials and methods
2.1. Chemicals
The chemicals and solutions used in this study were
purchased from Applichem (Germany), Merck
(Germany), Molekula (Germany), Sigma (USA), and
Roche (Germany). Ampicillin and kanamycin were
obtained from Sigma (USA). Protein size markers were
supplied by Fermentas (USA).
2.2. Bacterial strains and plasmids
E. coli BL21(DE3) strain, used for simultaneous expression
of β-lactamase and BLIP, was obtained from TÜBİTAKGEBI. This strain is compatible with the pET protein
expression vectors that are under the control of the T7
promoter. The strain used for purification of β-lactamase
was E. coli TB1 (from our laboratory stock). Plasmids
pUC18 and pET-26SJ were used as expression vectors
for the synthesis of β-lactamase and BLIP, respectively.
The pUC18 plasmid carried the bla gene of TEM-1
β-lactamase. The pET-26SJ plasmid was constructed by
inserting the BLIP bli gene with its native leader sequence
into pET-26b(+). The pET-26b(+) was used in the control
cells.
E. coli strains and plasmids used in this study are
summarized in Table 1.

Table 1. E. coli strains and plasmids used in this study.
E. coli strain

Feature

Recombinant protein/s synthesized

Reference

E. coli-Pu

E. coli BL21(DE3) with pUC18

β-lactamase

This study

E. coli-Pet

E. coli BL21(DE3) with pET-26b(+)

No β-lactamase and BLIP production

This study

E. coli-Sj

E. coli BL21(DE3) with pET-26SJ

BLIP with native leader signal sequence

This study

E. coli-PuPet

E. coli BL21(DE3) with pUC18 & pET-26b(+)

β-lactamase

This study

E. coli-PuSj

E. coli BL21(DE3) with pUC18 & pET-26SJ

β-lactamase and BLIP with native signal sequences

This study

E. coli TB1-Pu

E. coli TB1 with pUC18

β-lactamase

This study

Plasmid

Features (Resistance marker)

Expressed gene/s

Reference

pUC18

Cloning vector (ampicillin)

blaTEM-1 gene encoding β-lactamase

Lab stock

pET-26b(+)

Cloning vector (kanamycin)

No expression of blaTEM-1 and bli genes

Lab stock

pET-26SJ

bli gene from Streptomyces clavuligerus cloned
into pET-26b(+) (kanamycin)

bli gene encoding BLIP with its native eader signal
sequence

SJ*

* Plasmid pET-26SJ was a kind gift from Susan Jensen (University of Alberta)
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2.3. Cell growth
A single colony of E. coli was cultured in 5 mL of LB
medium (per liter: 10 g of tryptone, 5 g of yeast extract,
and 10 g of NaCl) at 37 °C and 180 rpm. The medium was
supplemented with 100 µg/mL of ampicillin and 50 µg/mL
of kanamycin to retain plasmids pUC18 and pET-26b(+)/
pET-26SJ, respectively. The preculture, grown to an OD600
of 0.7, was used to inoculate fresh LB medium. Cells
were incubated at 37 °C and 180 rpm. Cell growth was
monitored by measuring OD600. The values obtained from
triplicate readings were averaged to analyze cell growth
profiles. Culture volume was always kept at one fifth of the
flask volume for proper aeration.
2.4. Production of β-lactamase and BLIP
Synthesis of β-lactamase and BLIP was achieved at 37 °C.
β-lactamase was constitutively expressed in LB medium
with 100 µg/mL ampicillin by E. coli cells harboring the
pUC18 plasmid. For purification of β-lactamase, E. coli-Pu
cells were grown to a final OD600 of 1.50 at 37 °C. BLIP was
expressed in LB medium supplemented with 50 µg/mL
kanamycin by E. coli cells harboring the pET-26SJ plasmid.
Expression was induced with 0.2 mM isopropyl-β-D-1thiogalactopyranoside (IPTG) when the absorbance of
cells reached 0.5 at 600 nm. Cells were allowed to grow for
3 h after induction.
2.5. Extraction of periplasmic proteins
Periplasmic β-lactamase and BLIP were extracted from
E. coli cells by the osmotic shock procedure (Nossal and
Heppel, 1966). Cells were centrifuged at 4 °C and 7000
rpm and then resuspended in 20% sucrose solution
prepared in 30 mM Tris-HCl (pH of 8.0) with 1 mM
ethylenediaminetetraaceticacid
(EDTA).
Following
incubation at room temperature for 20 min, cells were
centrifuged at 9000 rpm. The pellet was resuspended in 5
mM ice-cold MgCl2 and gently incubated for 20 min. Cell
debris was removed from the periplasmic protein extract
by centrifugation at 9000 rpm.
Total protein concentration was determined by the
Bradford method (Bradford, 1976), using bovine serum
albumin (BSA) as the standard.
2.6. Purification of β-lactamase
Periplasmic protein extract containing β-lactamase was
dialyzed against 10 mM Tris-HCl buffer (pH 7.0) and then
concentrated by ultrafiltration through a polyethersulfone
membrane (Amicon) with a 10,000 molecular weight
cut-off. The concentrated protein extract was applied to
a DEAE-cellulose column equilibrated with 10 mM TrisHCl buffer (pH 7.0). Elution was achieved with 150 mM
Tris-HCl buffer (pH 7.0). Fractions with β-lactamase
activity were pooled and the purity of the enzyme was
verified by sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE).

2.7. Mass spectrometric analysis of β-lactamase
The β-lactamase band was excised from the Coomassie
Brilliant Blue stained gel and mass spectrometric analysis
of the protein was performed as previously described
(Shevchenko et al., 2007; Ozbalci et al., 2010).
2.8. Measurement of β-lactamase activity
The β-lactamase activity was measured by monitoring
the hydrolysis of its substrate CENTA (Calbiochem, Cat.
No. 219475). Upon CENTA hydrolysis, the color of the
reaction mixture turned from yellow to chrome yellow
(Jones et al., 1982; Bebrone et al., 2001). This change was
followed by measuring the absorbance at 405 nm.
The reaction was carried out at 25 °C in a total volume
of 1 mL in 50 mM potassium phosphate buffer (pH 7.0)
with 47 µM CENTA. For the inhibition experiments,
periplasmic protein extract containing BLIP was added to
the assay mixture and the mixture was incubated for 1 h
at 37 °C prior to activity measurement. One Unit (U) of
β-lactamase activity was defined as the amount of enzyme
that hydrolyzed 1 µmol of CENTA per minute at 25 °C.
Protein bands from native electrophoretic gels were
assayed for β-lactamase activity after the gel pieces were
cut into small pieces. The gels were mixed with 47 mM
CENTA in potassium phosphate buffer (pH 7.0) in a total
volume of 1 mL. This mixture was incubated for 2 days at
25 °C. Changes in the color of the mixture were monitored
spectrophotometrically.
2.9. Measurement of cell viability
Viabilities of induced and uninduced cultures of E. coliPuPet and E. coli-PuSj were measured after induction with
IPTG. Bacterial samples from actively growing cultures
were plated on LB plates with serial dilution. Colonies
formed on the plates were counted after an overnight
incubation at 37 °C. The number of colonies obtained from
triplicate experiments was averaged to get the number of
colony forming units (CFU).
2.10. Electrophoretic analysis of proteins
2.10.1. Denaturing gel electrophoresis
SDS-PAGE was used to analyze periplasmic proteins in
denatured form according to the method of Laemmli
(1970). Gels were stained with Coomassie G-250 dye
protocol to visualize the proteins (Blakesley and Boezi,
1977).
2.10.2. Native gel electrophoresis
Non-denaturing gel electrophoresis was used to confirm
the presence of the β-lactamase:BLIP complex. Extracted
periplasmic proteins were mixed with a sample buffer
without SDS and then loaded to the non-denaturing gels
(12.5% gels without SDS).
2.11. Western blot analysis of proteins
Electrophoretic transfer of native polyacrylamide gel
resolved proteins onto the PVDF membrane was carried
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out by semidry electroblotting. The unoccupied sites on
the PVDF membrane were blocked with 5% (w/v) nonfat
milk powder for 2 h at room temperature. The membrane
was washed three times for 10 min, each with PBS-Tween,
and then incubated with β-lactamase mouse anti-E.
coli monoclonal antibody (LSBio, Cat. No. LS-C74803)
overnight at 4 °C. This membrane was again washed
three times with PBS-Tween and then incubated for 2 h
with donkey anti-mouse-IgG-HRP conjugate (Santa Cruz
Biotechnology, Cat. No. sc-2318). Antibody detection
of β-lactamase was accomplished by the ECL method
(Western Blotting Detection Reagents, Amersham).
3. Results and discussion
3.1. β-Lactamase and BLIP synthesis
The first part of this work involved the analysis of the
expression of TEM-1 β-lactamase and BLIP in separate
hosts.
The β-lactamase synthesized in E. coli-Pu and E. coli
TB1-Pu cells was extracted from the periplasm using
the osmotic shock procedure. Periplasmic extracts
from E. coli BL21(DE3) or E. coli TB1 cells were used as
controls. Figure 1 shows the electrophoretic analysis of the
extracted periplasmic proteins from E. coli TB1 and E. coli
TB1-Pu cells on SDS-PAGE. The 28.9 kDa protein band
corresponding to the mature β-lactamase was visualized
only in the periplasmic extracts of β-lactamase expressing
cells.
The periplasmic extract was assayed for β-lactamase
activity and its yield in the crude extract was measured as
148.5 U/L culture. No measurable activity was detected
1

2

in the cytoplasmic fractions or in the culture filtrates.
In order to confirm that the 28.9 kDa band visualized
on the electrophoretic gels was the protein possessing
β-lactamase activity, β-lactamase was further purified
from the periplasmic extract. To this end, the crude
periplasmic extract was applied to a DEAE-cellulose
column. Electrophoretic analysis of the pooled fractions
from the column possessing β-lactamase activity revealed
a single protein band of 28.9 kDa (Figure 2). The estimated
specific activity, yield, and purification fold of β-lactamase
before and after purification are summarized in Table
2. For β-lactamase, 5.1-fold purification was achieved
with a yield of 21%. Total protein yield was 0.12 mg
of β-lactamase from 1 L of culture. Following tryptic
digestion, mass spectrometric analysis of the purified
protein band returned 10 peptides matching the TEM-1
β-lactamase. The results of the mass spectrometric analysis
are summarized in Table 3.
Periplasmic BLIP was expressed by E. coli-Sj cells.
Electrophoretic analysis of the periplasmic extract
obtained from these cells is presented in Figure 3, Lane
4. Upon induction with IPTG, cells expressed a protein
with a molecular weight of 17.5 kDa. This protein band
is missing in the absence of induction, suggesting that
the band corresponds to BLIP. The native signal peptide
allowed its transport to the periplasm.
3.2. In vitro inhibition of β-lactamase with BLIP
In order to test whether the synthesized β-lactamase
would be inhibited by the synthesized BLIP, β-lactamase
activity was measured in the absence and in the presence
of the inhibitor. Keeping the β-lactamase amount

3

34 kDa
β - lactamase

1

2

3

35 kDa

purified
β -lactamase

25 kDa

25 kDa

19 kDa

Figure 1. SDS-PAGE analysis of periplasmic protein extracts of
the cells. Lane 1: Protein size marker (34 kDa/25 kDa/19 kDa);
Lane 2: Periplasmic proteins obtained from E. coli TB1 cells; Lane
3: Periplasmic proteins obtained from E. coli TB1-Pu cells.

Figure 2. Analysis of the purified β-lactamase on SDS-PAGE.
Lane 1: Protein size marker (34 kDa/25 kDa); Lane 2: Periplasmic
proteins after ultrafiltration; Lane 3: β-lactamase eluted from a
DEAE-cellulose column with 150 mM Tris-HCl buffer (pH 7.0).

Table 2. Summary for β-lactamase purification from E. coli TB1-Pu cells.
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Specific activity (U/mg protein)

Yield (%)

Fold

Crude extract

50.8

100

1.0

Purified enzyme

256.9

21

5.1
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Table 3. Mass spectrometric analysis for β-lactamase.
SwissProt accession number

BLAT_ECOLX

1

Protein name

Beta-lactamase TEM

2

3

Molecular weight

Matched peptide sequences

31495

VKDAEDQLGAR/ VGYIELDLNSGK/
ILESFRPEER/ VDAGQEQLGR/
IHYSQNDLVEYSPVTEK/ LLTGELLTLASR/
QQLIDWMEADKVAGPLLR/
GIIAALGPDGKPSR/ IVVIYTTGSQATMDER/
QIAEIGASLIK

4

34 kDa
β -lactamase
26 kDa
BLIP

17 kDa

Figure 3. Electrophoretic analysis of periplasmic protein extracts.
Lane 1: Molecular weight marker; Lane 2: Protein extract from
E. coli-PuSj cells induced with 0.2 mM IPTG; Lane 3: Protein
extract from uninduced E. coli-PuSj cells; Lane 4: Protein extract
from E. coli-Sj induced with 0.2 mM IPTG.

constant, the amount of BLIP in the reaction mixture was
increased. The results presented in Table 4 show that even
in the presence of the crowding components such as other
proteins and ions in the periplasmic extract, incubation of
β-lactamase with BLIP resulted in β-lactamase inhibition
and an increase in the BLIP amount increased the extent of
β-lactamase inhibition.
Inhibition of β-lactamase by BLIP was further
investigated with the purified enzyme. The results
demonstrated that pure β-lactamase was more effectively
inhibited by BLIP. This could be explained by the absence
of the crowding components of the crude periplasmic
extract.

3.3. In vivo β-lactamase inhibition by BLIP
3.3.1. Co-expression of BLIP and β-lactamase in E. coliPuSj
Following confirmation of β-lactamase and BLIP
expression in separate E. coli hosts and demonstration
of β-lactamase inhibition by BLIP using crude cellular
extracts, simultaneous expression of β-lactamase and its
inhibitor protein in E. coli-PuSj cells was achieved. Under
uninduced conditions, only β-lactamase was expressed
in E. coli-PuSj cells (Figure 3, Lane 3), while both BLIP
and β-lactamase were expressed by the same cells under
induced conditions (Figure 3, Lane 2). Electrophoretic
analysis also showed that there was no leaky BLIP
expression under uninduced conditions and that BLIP
synthesis was induced only with the IPTG addition.
3.3.2. β-lactamase and BLIP complex formation in the
periplasm
The presence of β-lactamase and its complex with BLIP
in the periplasm of E. coli-Pu cells and E. coli-PuSj
cells was analyzed by Western blot analysis (Figure 4).
Upon induction, only β-lactamase was present in the
periplasmic extracts of E. coli-PuPet cells (Figure 4, Lane
1). Two bands were present in the extract of E. coli-PuSj
cells: one corresponding to β-lactamase and the other
corresponding to the size of the complex (Figure 4, Lane
2). This result demonstrates the formation of the BLIP:βlactamase complex in the E. coli periplasm when these two
proteins were co-expressed in the same host.

Table 4. Activity of β-lactamase with and without BLIP.
Extract from E. coli-Pu

Extract from E. coli-Sj

7.8 μg

-

7.8 μg

7.8 μg

69

7.8 μg

31.2 μg

90

7.8 μg

90

% inhibition

Purified β-lactamase
7.8 μg
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2

2
β - lactamase:BLIP
complex

β - lactamase

Optical density (600 nm)

1

Figure 4. Western Blot analysis of periplamic extracts from E.
coli-Pu (Lane 1) and E. coli-PuSj cells (Lane 2).

Bands of β-lactamase observed by Western blot in
native gels were also assayed, as described in the methods
section. Gel pieces containing the enzyme turned the color
of the reaction mixture to yellow, whereas the color of the
reaction mixture with the control gel pieces remained
unchanged.
3.3.3. Effect of periplasmic β-lactamase:BLIP complex
formation on cell growth
The formation of the complex was determined by
electrophoretic analysis of the periplasmic extract of
bacteria co-expressing the two proteins. However, this
did not give any clue about the extent of intracellular
β-lactamase inhibition by BLIP. Hence, β-lactamase
inhibition also required verification. The inhibition of
β-lactamase by its inhibitor protein is expected to retard
cell growth since β-lactamase that is engaged with an
inhibitor will not be able to hydrolyze the β-lactam
antibiotic, and this antibiotic will impose its lethal effect
on the peptidoglycan layer.
The growth rate of the control E. coli-PuPet cells
remained unchanged with IPTG induction (Figure 5).
The growth rate of E. coli-PuSj cells decreased when BLIP
synthesis was initiated with IPTG (Figure 6). Under all
conditions, there was a constitutive β-lactamase expression
in both cells.

uninduced

0.4

induced
0

1

2

3

4

5 6 7
Time (h)

8

9

10 11 12

Figure 6. Growth of E. coli-PuSj cells. Arrow indicates induction
with 0.2 mM IPTG.

The findings from the analysis of growth rates indicated
the formation of the β-lactamase:BLIP complex and the
inhibition of β-lactamase by BLIP. This should be the
reason for the observed decrease in the growth rate.
3.3.4. Effect of periplasmic β-lactamase:BLIP complex on
cell viability
Following the growth rate by simply measuring the
absorbance can sometimes be misleading since this does
not provide any information about cell viability. All
medium components, including dead cells and waste
products, contribute (along with culturable cells) to the
absorbance. To evaluate retardation of cell growth by
the β-lactamase:BLIP complex formation, the number of
viable cells was quantified on solid media after initiating
BLIP synthesis (Figure 7). The viable cell count dropped
with the induction of BLIP synthesis and decreased as a
function of induction time. This also points to the binding
of the inhibitor BLIP to β-lactamase.
1.E+04

CFU ( 10 5 )

Optical density (600 nm)

0.8

1.E+03

1.6
1.2
0.8

uninduced

0.4

induced

0

1

2

3

4

5 6 7
Time (h)

8

9

10 11 12

Figure 5. Growth of E. coli-PuPet (b) cells. Arrow indicates
induction with 0.2 mM IPTG.
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1.2

0

2

0

1.6

1.E+02

1.E+01

1.E+00

induced
uninduced
2

3

4
5
Time (h)

6

7

Figure 7. Colony forming units of E. coli-PuSj cells under
induced and uninduced conditions. Arrow indicates induction
with 0.2 mM IPTG.

BÜDEYRİ GÖKGÖZ et al. / Turk J Biol

3.3.5. Periplasmic β-lactamase activity with BLIP
synthesis
Analysis of growth rates demonstrated the effect of the
β-lactamase:BLIP complex formation in the periplasm.
It showed that cell growth has not ceased completely.
For this reason we tried to evaluate the ratio of bound to
unbound β-lactamase by measuring enzyme activity in
the periplasmic extracts of E. coli PuPet and E. coli PuSj
cells, both induced with IPTG. In other words, since it is
harder to measure the amount of β-lactamase bound to
the inhibitor, we quantified the free enzyme by measuring
residual activity with BLIP expression. The obtained value
was compared with the total enzyme activity measured in
the extracts of E. coli-PuPet cells harboring the identical
parent plasmids (pUC18 and pET-26b(+)) without the bli
gene.
In E. coli-PuPet cells, total β-lactamase activity was
91.8 U/L. However, when the extract from E. coli-PuSj
cells was assayed, total β-lactamase activity was only 4.3
U/L. This suggests that, with BLIP expression, about 95%
of the β-lactamase is found as complexed to BLIP.
The main goal of the current study was to investigate
β-lactamase inhibition by BLIP in live cells. The E. coliPuSj construct, which harbored both pUC18 and pET26SJ plasmids, was used as the model organism for
simultaneous expression of β-lactamase and BLIP. After
co-expression of these proteins in E. coli cells, analyses
were conducted to detect complex formation within cells.
Detection of complex formation can be facilitated by
tagging one or both proteins or by using fusion proteins,

but these methods may alter the structure and binding
properties of the proteins. Hence, we used native TEM1 β-lactamase and BLIP to investigate their interaction.
The results of this study demonstrated that BLIP formed
a complex with β-lactamase in the E. coli periplasm, but
this interaction was not sufficient to completely stop cell
growth. This could be related to the difference in the
copy number of the plasmids. The pUC18 is a high copy
number (500–700) plasmid, whereas the pET-26b(+) is a
low copy number (~40) plasmid. This may result in excess
β-lactamase. Furthermore, the in vitro inhibition constant
of BLIP is 0.3 nM; in the presence of crowding agents, the
inhibitor potential of BLIP may decrease.
Our results show that the protein based β-lactamase
inhibitor BLIP acts as an inhibitor even in the presence of
crowding agents. This is promising in terms of potential
utilization of other protein based inhibitors. Stoichiometry
is the key in providing the extent of inhibition and a
quantitative analysis of in vivo inhibition will be a valuable
future study.
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